v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net income $ 2,516,662 $ 1,444,295
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 262,496 248,688
Unrealized foreign exchange (gain) loss and other 14,669 (13,339)
Asset impairment charges 5,962 842
Stock-based compensation expense 90,069 84,146
Gain on sale of business 0 (4,422)
Deferred income taxes (382,975) (39,658)
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:    
Accounts receivable (318,271) (101,134)
Inventories (396,403) (146,375)
Other assets (23,729) (32,480)
Accounts payable 82,376 30,952
Deferred system revenue 141,122 (3,775)
Deferred service revenue 81,216 10,076
Other liabilities 420,279 241,586
Net cash provided by operating activities 2,493,473 1,719,402
Cash flows from investing activities:    
Proceeds from sale of assets 0 1,855
Proceeds from sale of business 0 16,833
Business acquisitions, net of cash acquired (470,887) 0
Capital expenditures (234,160) (176,252)
Purchases of available-for-sale securities (733,386) (795,124)
Proceeds from sale of available-for-sale securities 67,505 125,774
Proceeds from maturity of available-for-sale securities 524,677 418,447
Purchases of trading securities (101,342) (83,866)
Proceeds from sale of trading securities 95,734 84,919
Proceeds from other investments 795 614
Net cash used in investing activities (851,064) (406,800)
Cash flows from financing activities:    
Proceeds from issuance of debt, net of issuance costs 0 40,343
Proceeds from revolving credit facility 600,000 0
Repayment of debt (345,000) (70,000)
Common stock repurchases (1,394,217) (638,830)
Payment of dividends to stockholders (480,926) (420,086)
Issuance of common stock 36,912 26,356
Tax withholding payments related to vested and released restricted stock units (68,948) (42,819)
Contingent consideration payable and other, net (1,100) 0
Net cash used in financing activities (1,653,279) (1,105,036)
Effect of exchange rate changes on cash and cash equivalents (8,568) 10,175
Net (decrease) increase in cash and cash equivalents (19,438) 217,741
Cash and cash equivalents at beginning of period 1,434,610 1,234,409
Cash and cash equivalents at end of period 1,415,172 1,452,150
Supplemental cash flow disclosures:    
Income taxes paid 355,176 214,606
Interest paid 116,791 116,976
Non-cash activities:    
Contingent consideration (receivable) payable - financing activities 15,086 (8,570)
Dividends payable - financing activities 5,375 4,857
Unsettled common stock repurchase - financing activities 6,000 6,000
Accrued purchases of land, property and equipment - investing activities $ 22,305 $ 24,392

Source